ArticleMolecules (Basel, Switzerland)2019

The PPARγ Agonist Rosiglitazone Suppresses Syngeneic Mouse SCC (Squamous Cell Carcinoma) Tumor Growth through an Immune-Mediated Mechanism.

Raymond L Konger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.